complexes = {
    '/complexes/search': [{
        'params': {
            'complex_id': 'CPX-6163'
        },
        'response': {
            '_id': 'CPX-6163',
            'complex_name': 'Complement factor H complex',
            'alias': [],
            'molecules': [
                'P08603(2)'
            ],
            'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
            'experimental_evidence': 'intact:EBI-25828406',
            'description': 'Glycoprotein complex of the alternative pathway (AP) of complement activation that discriminate between self-structures and foreign structures to maintain a well-balanced immune response by modulating complement activation. Downregulates the AP by enhancing dissociation of the C3bBb (CPX-5601) complexes and by acting as a cofactor for factor I (P05156) in proteolytic inactivation of already-deposited C3b (CPX-973). It inactivates C3b by competitively binding it thereby reducing available C3b molecules for the next factor, factor B (P00751), of the cascade. Binds to self markers such as glycan structures to prevent complement activation and amplification on self-surfaces. ',
            'complex_assembly': 'Homodimer',
            'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
            'reactome_xref': [],
            'source': 'EBI',
            'source_url': 'https://www.ebi.ac.uk/complexportal/'
        }
    }, {
        'params': {
            'name': 'factor'
        },
        'response': [
            {
                '_id': 'CPX-6163',
                'complex_name': 'Complement factor H complex',
                'alias': [],
                'molecules': [
                    'P08603(2)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-25828406',
                'description': 'Glycoprotein complex of the alternative pathway (AP) of complement activation that discriminate between self-structures and foreign structures to maintain a well-balanced immune response by modulating complement activation. Downregulates the AP by enhancing dissociation of the C3bBb (CPX-5601) complexes and by acting as a cofactor for factor I (P05156) in proteolytic inactivation of already-deposited C3b (CPX-973). It inactivates C3b by competitively binding it thereby reducing available C3b molecules for the next factor, factor B (P00751), of the cascade. Binds to self markers such as glycan structures to prevent complement activation and amplification on self-surfaces. ',
                'complex_assembly': 'Homodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-6231',
                'complex_name': 'Coagulation factor XIIIa complex',
                'alias': [
                    'Coagulation factor XIIIa complex',
                    'FXIII complex',
                    'Coagulation factor F13 complex',
                    'FXIIIa complex'
                ],
                'molecules': [
                    'P00488(2)',
                    'P05160(2)'
                ],
                'evidence_code': 'ECO:0005547(biological system reconstruction evidence based on inference from background scientific knowledge used in manual assertion)',
                'experimental_evidence': None,
                'description': 'A protein-glutamine gamma-glutamyltransferase complex that is part of the last step of the coagulation pathway. Catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains of fibrin complexes (CPX-6225), thus stabilizing the fibrin clot (CPX-6230). Also cross-links Alpha-2-antiplasmin (SERPINF2 , P08697), or fibronectin (CPX-6232), to the alpha chains of fibrin. Its zymogen form is initially activated by minor proteolysis by alpha-thrombin complex (CPX-6222) and calcium ions. ',
                'complex_assembly': 'Heterotetramer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-2498',
                'complex_name': 'DNA fragmentation factor complex',
                'alias': [
                    'DFF complex',
                    'DFF40 -DFF45 complex',
                    'CAD-ICAD complex'
                ],
                'molecules': [
                    'O00273(1)',
                    'O76075(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-27120577',
                'description': 'Inhibits the catalytic activity of DFFB, a caspase-activated endo-nuclease that cleaves naked and chromosomal DNA during apoptotic cell death. During protein biosynthesis, DFFA acts as a specific chaperone, helping DFFB to adopt a catalytically competent structure. The complex then translocates into the nucleus, a process that requires cooperation of the nuclear localization signals found at the C-termini of these proteins. When apoptotic stimuli activate effector caspases such as caspase-3 (CPX-970), the DFFA is cleaved at residues 117 and 224, resulting in the dissociation of DFFB. Dissociated DFFB dimerizes, and cleaves chromosomal DNA.',
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-211225(identity)',
                    'R-HSA-211192(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-6205',
                'complex_name': 'Coagulation factor XIa complex',
                'alias': [
                    'FXI complex',
                    'Coagulation factor F11 complex',
                    'FXIa complex'
                ],
                'molecules': [
                    'P03951-PRO_0000027825(1)',
                    'P03951-PRO_0000027826(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'wwpdb:5qtx',
                'description': 'A serine-type endopeptidase complex of the intrinsic blood coagulation pathway (contact activation pathway). Cleaves Arg-|-Ala and Arg-|-Val bonds of factor IX (P00740) by limited proteolysis to form active factor IXa (CPX-4945) and contributes to factor VIIa-TF complex (CPX-2808) activation. Also binds platelet glycoprotein Ib:IX:V complex. The coagulation pathway is terminated when fibrinogen is cleaved to fibrin which in turn polymerizes to produce a clot. Its zymogen form is activated by limited proteolysis by factor XIIa (CPX-6209) and thrombin (CPX-6222) to form active factor XIa. Inhibited by antithrombin (SERPINC1, P01008). ',
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-158234(identity)',
                    'R-HSA-158143(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-6209',
                'complex_name': 'Coagulation factor XIIa complex',
                'alias': [
                    'FXII complex',
                    'Coagulation factor F12 complex',
                    'FXIIa complex',
                    'Hageman factor'
                ],
                'molecules': [
                    'P00748-PRO_0000027833(1)',
                    'P00748-PRO_0000027835(1)'
                ],
                'evidence_code': 'ECO:0005547(biological system reconstruction evidence based on inference from background scientific knowledge used in manual assertion)',
                'experimental_evidence': None,
                'description': 'A serine-type endopeptidase complex of the intrinsic blood coagulation pathway (contact activation pathway) whose formation in the plasma membrane initiates the blood coagulation process by initiating the cell-surface assembly and propagation of the coagulation protease cascade. Cleaves Arg-|-Ile bonds in factor VII (P08709) and factor XI (P03951) by limited proteolysis to form active factors VIIa (CPX-6211) and XIa (CPX-6205). Also activates prekallikrein (P03952) to form kallikrein (CPX-6234), angiotensinogins (P01019) to form angiotensins and kininogen (P01042) to form bradykinin (P01042-PRO_0000006688). The coagulation pathway is terminated when fibrinogen is cleaved to fibrin which in turn polymerizes to produce a clot. Its zymogen form is activated by damaged cell surface and by limited proteolysis by thrombin (CPX-6222) and kallikrein (CPX-6234) to form active factor XIIa. Inhibited by SERPING1 (P05155), SERPINA1 (P01009) and SERPINE1 (P05121). Factor XII and kallikrein activate each other in a reciprocal reaction. ',
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-158306(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-6216',
                'complex_name': 'Coagulation factor Va complex',
                'alias': [
                    'FVa complex',
                    'FV complex',
                    'Coagulation factor 5 complex'
                ],
                'molecules': [
                    'P12259-PRO_0000002979(1)',
                    'P12259-PRO_0000002981(1)'
                ],
                'evidence_code': 'ECO:0005547(biological system reconstruction evidence based on inference from background scientific knowledge used in manual assertion)',
                'experimental_evidence': None,
                'description': 'Part of the common blood coagulation pathway. Forms factor Va-Xa complex (CPX-6221) that cleaves prothrombin (P00734) by limited proteolysis to form thrombin (CPX-6222) and contributes to factor VIIa-TF complex (CPX-2808) activation. The coagulation pathway is terminated when fibrinogen is cleaved to fibrin which in turn polymerizes to produce a clot. Its zymogen form is activated by minor proteolysis by thrombin leading to a positive feedback cycle of factor Va and thrombin activation. Inhibited by Active Protein C (CPX-6224) and SERPINA5 (P05154). ',
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-140692(identity)',
                    'R-HSA-140661(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-6211',
                'complex_name': 'Coagulation factor VIIa complex',
                'alias': [
                    'FVIIa complex',
                    'FVII complex',
                    'Coagulation factor 7 complex'
                ],
                'molecules': [
                    'P08709-PRO_0000027730(1)',
                    'P08709-PRO_0000027731(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'wwpdb:5tqg',
                'description': 'Part of the extrinsic blood coagulation pathway (tissue factor pathway) whose formation in the plasma membrane initiates the blood coagulation process by initiating the cell-surface assembly and propagation of the coagulation protease cascade. Forms factor VIIa-TF complex (CPX-2808) that activates coagulation factors IX (P00740) and X (P00742) by limited proteolysis to form active factors IXa (CPX-4945) and Xa (CPX-6215). The coagulation pathway is terminated when fibrinogen is cleaved to fibrin which in turn polymerizes to produce a clot. Its zymogen form is activated by selective cleavage of Arg-|-Ile bonds to form active factor VIIa. Activation is triggered by trauma and minor proteolysis by thrombin (CPX-6222), factor Xa (CPX-6215), factor XIa (CPX-6205) and factor XIIa (CPX-6209). Also constitutively activated at very low levels. Inhibited by complex formation with TFPI (P10646/P48307) and factor Xa. ',
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-140751(identity)',
                    'R-HSA-140733(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-6215',
                'complex_name': 'Coagulation factor Xa complex',
                'alias': [
                    'FX complex',
                    'Coagulation factor F10 complex',
                    'FXa complex'
                ],
                'molecules': [
                    'P00742-PRO_0000027788(1)',
                    'P00742-PRO_0000027789(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'wwpdb:3q3k',
                'description': 'A serine-type endopeptidase complex of the common blood coagulation pathway. Cleaves Arg-|-Thr and then Arg-|-Ile bonds in prothrombin (P00734) by limited proteolysis to form thrombin (CPX-6222) and contributes to factor VIIa-TF complex (CPX-2808) activation. While factor Xa is constitutively active, it is 300,000-fold more active when bound to factor Va (CPX-6216). The coagulation pathway is terminated when fibrinogen is cleaved to fibrin which in turn polymerizes to produce a clot. Its zymogen form is activated by limited proteolysis by factor VIIa-TF complex and factor VIIIa-IXa complex (CPX-6204) to form active factor Xa. Inhibited by antithrombin (SERPINC1, P01008). ',
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-159785(identity)',
                    'R-HSA-140739(identity)',
                    'R-HSA-140649(identity)',
                    'R-HSA-140689(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-1956',
                'complex_name': 'CCAAT-binding factor complex',
                'alias': [
                    'Nuclear transcription factor Y complex',
                    'NF-Y transcription factor complex',
                    'CCAAT box DNA-binding factor complex',
                    'CBF complex'
                ],
                'molecules': [
                    'P23511(1)',
                    'P25208(1)',
                    'Q13952(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-6672292',
                'description': 'Transcription factor which binds to the CCAAT box, which occurs in 30% of eukaryotic promoters and appears to be crucial for promoter activity. May also play a role in histone methylation and some acetylation through recruitment of relevant enzymes to active promoters.',
                'complex_assembly': 'Heterotrimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-381204(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-256',
                'complex_name': 'YAP1-TEAD1 transcription factor complex',
                'alias': [
                    'TEF-1 - YAP1 complex',
                    'YAP-TEAD complex'
                ],
                'molecules': [
                    'P28347(1)',
                    'P46937(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-16148305',
                'description': "Transcription factor complex of enhancer factor TEF-1 (TEAD) and coactivator YAP1. Plays key role in Hippo signaling pathway involved in organ size control and tumor supression by restricting proliferation and promoting apoptosis. Connective tissue growth factor (CTGF) has been identified as a direct target gene. Associated also with Sveinsson's chorioretinal atrophy caused by TEAD mutation.",
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"-\"(ceitec)",
                'reactome_xref': [
                    'R-HSA-8869643(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-6204',
                'complex_name': 'Coagulation factor VIIIa-IXa complex',
                'alias': [
                    'FVIIIa-FIXa complex',
                    'FVIII-FIX complex',
                    'Coagulation factor F8-F9 complex',
                    'Intrinsic tenase complex'
                ],
                'molecules': [
                    'CPX-4945(1)',
                    'CPX-929(1)'
                ],
                'evidence_code': 'ECO:0005547(biological system reconstruction evidence based on inference from background scientific knowledge used in manual assertion)',
                'experimental_evidence': None,
                'description': 'A serine-type endopeptidase complex of the intrinsic blood coagulation pathway (contact activation pathway). Cleaves Arg-|-Ile bonds of factor X (P00742) by limited proteolysis to form active factor Xa (CPX-6215) in the presence of vitamin K, Ca2+ ions, phospholipids and Factor VII (P08709). The coagulation pathway is terminated when fibrinogen is cleaved to fibrin which in turn polymerizes to produce a clot. ',
                'complex_assembly': 'Heterotetramer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-158392(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-415',
                'complex_name': 'DNA replication factor C complex',
                'alias': [
                    'DNA replication factor C complex',
                    'RFC',
                    'RFC complex',
                    'Activator 1 complex',
                    'RFC Heteropentamer'
                ],
                'molecules': [
                    'P35249(1)',
                    'P35250(1)',
                    'P35251(1)',
                    'P40937(1)',
                    'P40938(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-1169835',
                'description': 'DNA-dependent ATPase that functions with PCNA (CPX-538) to confer processivity on DNA polymerase delta. RFC uses the energy of ATP binding and hydrolysis to recruit PCNA to DNA, break one clamp interface, and topologically link the clamp to primed template DNA during the duplication of chromosomal DNA prior to cell division. After loading PCNA, RFC then dissociates, allowing PCNA to function with Pol-delta RFC consists of five subunits in a spiral arrangement, each subunit being AAA+ family proteins, and the complex contains four ATP sites located at subunit interfaces. A cavity exists in the center of this protein spiral that accommodates double-stranded DNA. Conserved polar and positively charged residues line the cavity and interact with DNA. There is a gap between two subunits, RFC1 and RFC5, which may provide an exit path for single-stranded DNA from the central cavity.',
                'complex_assembly': 'Heteropentamer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-68436(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-2525',
                'complex_name': 'MLXIP-MLX transcription factor complex',
                'alias': [
                    'MondoA-MLX complex'
                ],
                'molecules': [
                    'Q9HAP2(0)',
                    'Q9UH92(0)'
                ],
                'evidence_code': 'ECO:0005547(biological system reconstruction evidence based on inference from background scientific knowledge used in manual assertion)',
                'experimental_evidence': None,
                'description': "Transcriptional activator which recognizes an E box hexanucleotide DNA consensus sequence 5'-CACGTG-3' located within gene promoters. Regulates genes involved in glucose and glutamine metabolism. MondoA associates with the mitochondrial outer membrane, where it acts as a nutrient senor, binding glycolytic intermediates such as glucose 6-phosphate which trigger migration to the nucleus.",
                'complex_assembly': [],
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-569',
                'complex_name': 'Chromatin assembly factor 1 complex',
                'alias': [
                    'p150-p60-p48 complex',
                    'CAF-1',
                    'CAF1'
                ],
                'molecules': [
                    'Q09028(1)',
                    'Q13111(1)',
                    'Q13112(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-1236705',
                'description': 'Catalyzes de novo assembly of nucleosomes onto newly synthesized DNA, involved in chromatin assembly following both DNA replication and some forms of DNA repair. Binds modified histones H3 and H4 and deposits them as a tetramer, preferentially onto replicating DNA, in a step coupled to the replication process. This is followed by deposition of a pair of dimers of histones H2A and H2B mediated by other factor(s) in a process not necessarily coupled to DNA replication. The histone core of nucleosomes consists of two copies of each of histones H2A, H2B, H3 and H4. CAF-1 nucleosome deposition is thought to be involved in heterochromatic silencing. CAF-1 is essential for S-phase progression in mammalian cells.',
                'complex_assembly': 'Heterotrimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-61',
                'complex_name': 'NKX2-5 transcription factor complex',
                'alias': [
                    'NKX2E homodimer complex'
                ],
                'molecules': [
                    'P52952(2)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-10636810',
                'description': 'Nkx-2.5 is an evolutionary conserved transcription factor important for the specification and differentiation of cardiomyocytes during heart development and also required for spleen development. It binds DNA either as a monomer, homodimer, or heterodimer complex to activate or inhibit expression of genes.',
                'complex_assembly': 'Homodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-79',
                'complex_name': 'General transcription factor TFIIF complex',
                'alias': [
                    'TFIIF complex',
                    'RNA polymerase II preinitiation complex TFIIF',
                    'RAP30-RAP74 complex'
                ],
                'molecules': [
                    'P13984(1)',
                    'P35269(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-1030578',
                'description': 'TFIIF is a general transcription factor associated with RNA polymerase II (CPX-2387/CPX-7481). It prevents the non-specific interaction of RNA Pol II with DNA and stabilizes the pre-initiation complex (PIC), in particular stabilizing TFIIB within the PIC and stimulating the recruitment of TFIIH, thus promoting initiation and elongation. May also interact with paused Pol II causing a conformational change that facilitates the re-entry into elongation mode.',
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"-\"(ceitec)",
                'reactome_xref': [
                    'R-HSA-109631(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-2530',
                'complex_name': 'MLXIPL-MLX transcription factor complex',
                'alias': [
                    'ChREBP-MLX complex'
                ],
                'molecules': [
                    'Q9NP71(0)',
                    'Q9UH92(0)'
                ],
                'evidence_code': 'ECO:0005547(biological system reconstruction evidence based on inference from background scientific knowledge used in manual assertion)',
                'experimental_evidence': None,
                'description': "Glucose-responsive transcriptional activator which recognizes an E box hexanucleotide DNA consensus sequence 5'-CACGTG-3' located within gene promoters. Regulates transcription of genes encoding enzymes involved in de novo lipogenesis such as liver-type pyruvate kinase, acetyl-CoA carboxylase 1, and fatty acid synthase.",
                'complex_assembly': [],
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-915',
                'complex_name': 'General transcription factor complex TFIID',
                'alias': [
                    'Transcription factor complex IID'
                ],
                'molecules': [
                    'O00268(2)',
                    'P20226(1)',
                    'P21675(1)',
                    'P49848(2)',
                    'Q12962(1)',
                    'Q15542(2)',
                    'Q15543(1)',
                    'Q15544(1)',
                    'Q15545(1)',
                    'Q16514(2)',
                    'Q16594(2)',
                    'Q5VWG9(1)',
                    'Q6P1X5(1)',
                    'Q7Z7C8(1)'
                ],
                'evidence_code': 'ECO:0005547(biological system reconstruction evidence based on inference from background scientific knowledge used in manual assertion)',
                'experimental_evidence': None,
                'description': 'General transcription factor complex that acts as the primary core promoter recognition factor in the initiation of RNA polymerase II (Pol II)-dependent transcription. The TBP subunit of TFIID recognizes and binds to the TATA box (if present), while TAF1 and TAF2 interact with the Initiator element (Inr), and TAF1 and the TAF6-TAF9 module recognizes the downstream core promoter element (DPE). Other core promoter elements, such as the motif ten element (MTE), may also be involved. Binding of the general transcription factor complex TFIIA (CPX-519) enhances binding of TFIID to the core promoter and nucleates pre-initiation complex (PIC) assembly. Following recruitment of TFIIA to TFIID, TFIIB, TFIIF (CPX-79), Pol II, TFIIE and TFIIH are successively assembled at the core promoter, allowing the PIC to initiate Pol II transcription. While TFIID is essential for transcription and its post-mitotic reinitiation, the loss of one or more subunits does not harm ongoing transcription during any given cell cycle. TFIID promoter binding appears to be regulated by histone modifications: TAF1 bromodomains (1361-1617 aa, IPR001487) bind the modified histone tails of acetylated H4K16, H4K5/K12 and H4K8/K16. TAF1 also appears to exhibit histone acetyltransferase activity towards histones H3 and H4. TAF3 and the PHD domains of other TFIID subunits bind modified histone tails carrying trimethylated H3K4 in combination with acetylated H3K9 and H3K14. TAF1 phosphorylates TP53 (P04637) on Thr-55, leading to TP53 degradation and G1 cell cycle progression. Spermatocytes contain variants of TAF-containing complexes, including the TAF4B variant (CPX-930). ',
                'complex_assembly': 'Heterononadecamer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-109626(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-891',
                'complex_name': 'DSIF transcription elongation factor complex',
                'alias': [
                    'HSPT4-HSPT5 complex',
                    'DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole) sensitivity-inducing factor complex',
                    'SPT4-SPT5 complex'
                ],
                'molecules': [
                    'O00267(1)',
                    'P63272(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-11133933',
                'description': 'An essential RNA polymerase II elongation factor which functions in the control of RNAP II processivity. Mediates both activation and inhibition of transcription elongation, and plays a role in pre-mRNA processing. Required for promoter-proximal pausing when elongating Pol II pauses near the promoter, about 20-60 base pairs downstream of the transcription start site, a key event in post-initiation regulation of transcription. SUPT5H docks DSIF to Pol II near the RNA exit channel where it facilitates capping of the nascent RNA . The negative elongation factor (NELF, CPX-6267) complex then recognizes the Pol II-SUPT5H interface and associates with the elongation complex as it transcribes through the promoter-proximal region. Phosphorylation of SUPT5H by P-TEFb (CPX-222/CPX-321/CPX-322) appears to trigger dissociation of NELF from Pol II, enabling Pol II reactivation and resumption of elongation.',
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"-\"(ceitec)",
                'reactome_xref': [
                    'R-HSA-112420(identity)',
                    'R-HSA-170705(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-1971',
                'complex_name': 'E2F1-DP1 transcription factor complex',
                'alias': [
                    'E2F1-DP1 complex',
                    'E2F1:DP1'
                ],
                'molecules': [
                    'Q01094(1)',
                    'Q14186(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-6878536',
                'description': "Transcription factor complex which binds DNA through the E2 recognition site, 5'-TTTC[CG]CGC-3', typically associated with the promoters of genes active in S phase. Activates genes that stimulate DNA synthesis and cell cycle advancement.",
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-6267',
                'complex_name': 'NELF negative elongation factor complex ',
                'alias': [],
                'molecules': [
                    'P18615(1)',
                    'Q8IXH7(1)',
                    'Q8WX92(1)',
                    'Q9H3P2(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-6109790',
                'description': 'Negatively regulates the elongation of transcription by RNA polymerase II. Required for promoter-proximal pausing when elongating Pol II pauses near the promoter, about 20-60 base pairs downstream of the transcription start site, a key event in post-initiation regulation of transcription. SUPT5H (O00267) docks the DSIF complex (CPX-891) to Pol II near the RNA exit channel where it facilitates capping of the nascent RNA. NELF then recognizes the Pol II-SUPT5H interface and associates with the elongation complex as it transcribes through the promoter-proximal region. Binding of newly synthesized RNA by NELF may stabilize its interactions with elongating Pol II at specific loci. Phosphorylation of SUPT5H by P-TEFb (CPX-222/CPX-321/CPX-322) appears to trigger dissociation of NELF from Pol II, enabling Pol II reactivation and resumption of elongation.',
                'complex_assembly': 'Heterotetramer',
                'complex_source': "psi-mi:\"MI:0486\"(UniProt)",
                'reactome_xref': [
                    'R-HSA-112432(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-1972',
                'complex_name': 'E2F2-DP1 transcription factor complex',
                'alias': [
                    'E2F2:DP1',
                    'E2F2-DP1 complex'
                ],
                'molecules': [
                    'Q14186(1)',
                    'Q14209(1)'
                ],
                'evidence_code': 'ECO:0005546(biological system reconstruction evidence based on paralogy evidence used in manual assertion)',
                'experimental_evidence': None,
                'description': "Transcription factor complex which binds DNA through the E2 recognition site, 5'-TTTC[CG]CGC-3', typically associated with active promoters in S phase, activating genes that stimulate DNA synthesis and cell cycle advancement.",
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [
                    'R-HSA-9007512(see-also)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-3082',
                'complex_name': 'USF1 upstream stimulatory factor complex',
                'alias': [
                    'USF1 major late transcription factor complex'
                ],
                'molecules': [
                    'P22415(2)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-9515320',
                'description': "Ubiquitous upstream stimulatory factor transcription factor that binds to a symmetrical DNA sequence (E-boxes) (5'-CACGTG-3') that is found in a variety of viral and cellular promoters.",
                'complex_assembly': 'Homodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-519',
                'complex_name': 'General transcription factor complex TFIIA',
                'alias': [
                    'Transcription factor IIA',
                    'Transcription initiation factor IIA'
                ],
                'molecules': [
                    'P52655(1)',
                    'P52657(1)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-1570464',
                'description': 'Transcription factor complex that regulates transcription initiation from RNA polymerase II promoters. Binding to the transcription factor complex TFIID-TBP enhances assembly of the transcriptional preinitiation complex PIC and its binding to the DNA at the TATA-box by displacing transcription inhibitors, such as DRAP1 (Q14919) or DR1 (Q01658), from TBP (P20226).',
                'complex_assembly': 'Heterodimer',
                'complex_source': "psi-mi:\"-\"(ceitec)",
                'reactome_xref': [
                    'R-HSA-109629(identity)'
                ],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            },
            {
                '_id': 'CPX-3083',
                'complex_name': 'USF2 upstream stimulatory factor complex',
                'alias': [
                    'USF2 major late transcription factor complex'
                ],
                'molecules': [
                    'Q15853(2)'
                ],
                'evidence_code': 'ECO:0000353(physical interaction evidence used in manual assertion)',
                'experimental_evidence': 'intact:EBI-9515527',
                'description': "Ubiquitous upstream stimulatory factor transcription factor that binds to a symmetrical DNA sequence (E-box) (5'-CACGTG-3') that is found in a variety of viral and cellular promoters.",
                'complex_assembly': 'Homodimer',
                'complex_source': "psi-mi:\"MI:0469\"(IntAct)",
                'reactome_xref': [],
                'source': 'EBI',
                'source_url': 'https://www.ebi.ac.uk/complexportal/'
            }
        ]
    }]
}
